Ahmet Hoke

Ahmet Hoke

Auto-generated profile, based on publicly available information

Ahmet Hoke

Department of Neurology Johns Hopkins University School of Medicine Baltimore Maryland USA

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2004 in Developmental Biology
Verified
Journal Article
Closed access
IGIrene Ginis
Irene Ginis
YLYongquan Luo
Yongquan Luo
TMTakumi Miura
Takumi Miura
STScott Thies
Scott Thies
RBRalph Brandenberger
Ralph Brandenberger
MRMahendra S Rao
Mahendra S Rao

1 October 2009 in Critical Care Medicine
Verified
Journal Article
Closed access
RSRobert D. Stevens
Robert D. Stevens
SMScott A. Marshall
Scott A. Marshall
DCDavid R. Cornblath
David R. Cornblath
AHAhmet Hoke
Ahmet Hoke
DNDale M. Needham
Dale M. Needham
TSTarek Sharshar
Tarek Sharshar
Neuromuscular dysfunction is prevalent in critically ill patients, is associated with worse short-term outcomes, and is a determinant of long-term disability in intensive care unit survivors. Diagnosis is made with the help of clinical, electrophysiological, and morphological observations; however, the lack of a consistent nomenclature remains a barrier to research. We propose a simple framework for diagnosing and classifying neuromuscular disorders acquired in critical illness.

1 February 2008 in Biomaterials
Verified
Journal Article
Closed access
Sing Yian ChewSing Yian Chew
Sing Yian Chew
RMRuifa Mi
Ruifa Mi
AHAhmet Hoke
Ahmet Hoke
KLKam W Leong
Kam W Leong

1 November 1995 in Experimental Neurology
Verified
Journal Article
Closed access
RMRobert J. Mckeon
Robert J. Mckeon
AHAhmet Höke
Ahmet Höke
JSJerry Silver
Jerry Silver

20 September 2006 in The Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
AHA. Höke
A. Höke
RRR. Redett
R. Redett
HHH. Hameed
H. Hameed
RJR. Jari
R. Jari
CZC. Zhou
C. Zhou
TBT. M. Brushart
T. M. Brushart
Schwann cell phenotype is classified as either myelinating or nonmyelinating. Additional phenotypic specialization is suggested, however, by the preferential reinnervation of muscle pathways by motoneurons. To explore potential differences in growth factor expression between sensory and motor nerve, grafts of cutaneous nerve or ventral root were denervated, reinnervated with cutaneous axons, or reinnervated with motor axons. Competitive reverse transcription-PCR was performed on normal cutaneous nerve and ventral root and on graft preparations 5, 15, and 30 d after surgery. mRNA for nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), vascular endothelial growth factor, hepatocyte growth factor, and insulin-like growth factor-1 was expressed vigorously by denervated and reinnervated cutaneous nerve but minimally by ventral root. In contrast, mRNA for pleiotrophin (PTN) and glial cell line-derived neurotrophic factor was upregulated to a greater degree in ventral root. ELISA confirmed that NGF and BDNF protein were significantly more abundant in denervated cutaneous nerve than in denervated ventral root, but that PTN protein was more abundant in denervated ventral root. The motor phenotype was not immutable and could be modified toward the sensory phenotype by prolonged reinnervation of ventral root by cutaneous axons. Retrograde labeling to quantify regenerating neurons demonstrated that cutaneous nerve preferentially supported cutaneous axon regeneration, whereas ventral root preferentially supported motor axon regeneration. Schwann cells thus express distinct sensory and motor phenotypes that are associated with the support of regeneration in a phenotype-specific manner. These findings suggest that current techniques of bridging gaps in motor and mixed nerve with cutaneous graft could be improved by matching axon and Schwann cell properties.

9 March 2020 in Nature Reviews Neuroscience
Verified
Journal Article
Closed access
PDF file
MCMichael P. Coleman
Michael P. Coleman
AHAhmet Höke
Ahmet Höke